Offerings (SEC Form D)
Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.
Offerings at a glance — 6 offerings, 8 filings (one row per SEC file number)
| File no. | Original Form D | Latest filing | Amendments | Offered (latest) | Sold (latest) | Industry (latest) |
|---|
| 021-495002 | Oct 17, 2023 EDGAR ↗ | Oct 17, 2023 D EDGAR ↗ | 0 | $15,000,000 | $3,090,000 | Hospitals and Physicians |
| 021-441501 | Apr 12, 2022 EDGAR ↗ | Apr 12, 2022 D EDGAR ↗ | 0 | $2,371,166,848 | $2,371,166,848 | Other Health Care |
| 021-401053 | May 28, 2021 EDGAR ↗ | Dec 15, 2021 D/A EDGAR ↗ | 1 latest Dec 15, 2021 | Indefinite | $11,321,875 | Other Health Care |
| 021-392057 | Mar 12, 2021 EDGAR ↗ | Mar 12, 2021 D EDGAR ↗ | 0 | $31,968,000 | $31,968,000 | Other Health Care |
| 021-358698 | Jan 22, 2020 EDGAR ↗ | Jan 22, 2020 D EDGAR ↗ | 0 | $2,345,374 | $2,345,374 | Other Health Care |
| 021-353280 | Nov 13, 2019 EDGAR ↗ | Nov 14, 2019 D/A EDGAR ↗ | 1 latest Nov 14, 2019 | $24,492,608 | $24,492,608 | Other Health Care |
Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.
Oct 17, 2023 D Hospitals and Physicians — $3,090,000 sold of $15,000,000 · 13 investors EDGAR ↗
| Filing | Form D filed Oct 17, 2023SEC file no. 021-495002 · accession 0001486189-23-000038 |
|---|
| Raise progress | $3,090,000 sold of $15,000,000 offered (21%) · $11,910,000 remaining · first sale Sep 30, 2023 |
|---|
| Filing timing | Date of first sale: Sep 30, 2023 · Form D filed: Oct 17, 2023 (17 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 1,120 days (3.1 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 13 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $50,000 |
|---|
| Securities offered | Debt; Option, warrant or other right to acquire; Other: Convertible promissory note convertible to Common Stock and Warrants to Purchase Common Stock |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Hospitals and Physicians |
|---|
| Who is paid to sell it | Emerson Equity LLC — FINRA BrokerCheck CRD 130032 ↗ Solicits in: All States |
|---|
| Money to insiders | Sales commissions: $309,000 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 Issuer's note: 10% of proceeds. |
|---|
| Signed by | Elisa Luqman, Chief Legal Officer (Oct 17, 2023) |
|---|
| Market context | Minimum investment: $50,000. Typical range for similar offerings: $10,000–$70,605.
Offering size: $15,000,000. Typical range: $1,120,617–$11,272,500.
Investors: 13. Typical range: 3–24."Similar" = Hospitals and Physicians, Rule 506(b). Based on 147 Form D filings 2021–2026 in the same industry and exemption (Hospitals and Physicians, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 97, offering size 124, investors 115. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Apr 12, 2022 D Other Health Care — $2,371,166,848 sold of $2,371,166,848 · 123 investors EDGAR ↗
| Filing | Form D filed Apr 12, 2022SEC file no. 021-441501 · accession 0001607062-22-000270 |
|---|
| Raise progress | $2,371,166,848 sold of $2,371,166,848 offered (100%) · $0 remaining · first sale Apr 1, 2022 |
|---|
| Filing timing | Date of first sale: Apr 1, 2022 · Form D filed: Apr 12, 2022 (11 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 1,667 days (4.6 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 123 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity · business combination transaction |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Warren Hosseinion, President (Apr 12, 2022)Signed by an authorized representative. |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $2,371,166,848. Typical range: $829,831–$9,999,998.
Investors: 123. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Dec 15, 2021 D/A Other Health Care — $11,321,875 sold of Indefinite · 73 investors EDGAR ↗
| Filing | Form D/A (amendment) filed Dec 15, 2021 · amends 0001486189-21-000009 ↗SEC file no. 021-401053 · accession 0001486189-21-000010 · filing 2 of 2 in this offering |
|---|
| Raise progress | $11,321,875 sold of Indefinite offered · Indefinite remaining · first sale May 14, 2021 |
|---|
| Filing timing | Date of first sale: May 14, 2021 · Original Form D filed: May 28, 2021 (14 days after first sale) · This amendment (Form D/A) filed: Dec 15, 2021 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 1,989 days (5.4 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. This filing is an amendment dated Dec 15, 2021. Most recent amendment for this offering in our index: this filing, Dec 15, 2021. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 73 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $50,000 |
|---|
| Securities offered | Equity; Other: Common stock and warrants to purchase common stock |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Warren Hosseinion, CEO (Dec 15, 2021) |
|---|
| Changes vs previous filing | - total sold: $1,925,000 (May 28, 2021) → $11,321,875 (Dec 15, 2021)
- total offering: $2,000,000 (May 28, 2021) → Indefinite (Dec 15, 2021)
- remaining: $75,000 (May 28, 2021) → Indefinite (Dec 15, 2021)
- investors: 12 (May 28, 2021) → 73 (Dec 15, 2021)
- related persons added (Dec 15, 2021): Mark Fawcett, Brandon Sims, Michael Bowen
Compared with the D filed May 28, 2021 ( EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
|---|
| Market context | Minimum investment: $50,000. Typical range for similar offerings: $10,000–$54,310.
Offering size: Indefinite. Typical range: $829,831–$9,999,998.
Investors: 73. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
May 28, 2021 D Other Health Care — $1,925,000 sold of $2,000,000 · 12 investors EDGAR ↗
| Filing | Form D filed May 28, 2021SEC file no. 021-401053 · accession 0001486189-21-000009 · filing 1 of 2 in this offering |
|---|
| Raise progress | $1,925,000 sold of $2,000,000 offered (96%) · $75,000 remaining · first sale May 14, 2021 |
|---|
| Filing timing | Date of first sale: May 14, 2021 · Form D filed: May 28, 2021 (14 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 1,989 days (5.4 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: Dec 15, 2021 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 12 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $50,000 |
|---|
| Securities offered | Equity; Other: Common stock and warrants to purchase common stock |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Warren Hosseinion, CEO (May 28, 2021) |
|---|
| Market context | Minimum investment: $50,000. Typical range for similar offerings: $10,000–$54,310.
Offering size: $2,000,000. Typical range: $829,831–$9,999,998.
Investors: 12. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Mar 12, 2021 D Other Health Care — $31,968,000 sold of $31,968,000 · 58 investors EDGAR ↗
| Filing | Form D filed Mar 12, 2021SEC file no. 021-392057 · accession 0001486189-21-000008 |
|---|
| Raise progress | $31,968,000 sold of $31,968,000 offered (100%) · $0 remaining · first sale Mar 2, 2021 Issuer's note: Total Offering Amount includes common stock, and options and warrants on as-converted basis, calculated at the closing price of the Issuer on OTC Markets on the date of closing of the merger, March 2, 2021 of $2.16 per share. |
|---|
| Filing timing | Date of first sale: Mar 2, 2021 · Form D filed: Mar 12, 2021 (10 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 2,062 days (5.6 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 58 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity; Option, warrant or other right to acquire · business combination transaction |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Warren Hosseinion, Chief Executive Officer (Mar 12, 2021) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $31,968,000. Typical range: $829,831–$9,999,998.
Investors: 58. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Jan 22, 2020 D Other Health Care — $2,345,374 sold of $2,345,374 · 17 investors EDGAR ↗
| Filing | Form D filed Jan 22, 2020SEC file no. 021-358698 · accession 0000935836-20-000037 |
|---|
| Raise progress | $2,345,374 sold of $2,345,374 offered (100%) · $0 remaining · first sale Oct 24, 2019 |
|---|
| Filing timing | Date of first sale: Oct 24, 2019 · Form D filed: Jan 22, 2020 (90 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 2,557 days (7.0 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 17 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $25,000 |
|---|
| Securities offered | Equity; Option, warrant or other right to acquire; Other: Common Stock and Warrants to Purchase Common Stock · business combination transaction |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | Emerson Equity LLC — FINRA BrokerCheck CRD 130032 ↗ Solicits in: All States |
|---|
| Money to insiders | Sales commissions: $234,538 (est.) · Finder's fees: $0 (est.) · Proceeds to officers, directors, promoters: $0 (est.) Issuer's note: Estimated sales commissions are current as of January 21, 2020. Warrants will also be granted. |
|---|
| Signed by | Jacob Margolin, Chief Executive Officer (Jan 22, 2020) |
|---|
| Market context | Minimum investment: $25,000. Typical range for similar offerings: $10,000–$54,310.
Offering size: $2,345,374. Typical range: $829,831–$9,999,998.
Investors: 17. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Nov 14, 2019 D/A Other Health Care — $24,492,608 sold of $24,492,608 · 114 investors EDGAR ↗
| Filing | Form D/A (amendment) filed Nov 14, 2019 · amends 0000935836-19-000587 ↗SEC file no. 021-353280 · accession 0000935836-19-000590 · filing 2 of 2 in this offering |
|---|
| Raise progress | $24,492,608 sold of $24,492,608 offered (100%) · $0 remaining · first sale Oct 29, 2019 |
|---|
| Filing timing | Date of first sale: Oct 29, 2019 · Original Form D filed: Nov 13, 2019 (15 days after first sale) · This amendment (Form D/A) filed: Nov 14, 2019 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 2,552 days (7.0 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. This filing is an amendment dated Nov 14, 2019. Most recent amendment for this offering in our index: this filing, Nov 14, 2019. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 114 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $1 |
|---|
| Securities offered | Equity; Option, warrant or other right to acquire; Other: Common Stock and Warrants to Purchase Common Stock · business combination transaction |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Jacob Margolin, Chief Executive Officer (Nov 14, 2019) |
|---|
| Changes vs previous filing | No change in the fields compared.Compared with the D filed Nov 13, 2019 ( EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
|---|
| Market context | Minimum investment: $1. Typical range for similar offerings: $10,000–$54,310.
Offering size: $24,492,608. Typical range: $829,831–$9,999,998.
Investors: 114. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Nov 13, 2019 D Other Health Care — $24,492,608 sold of $24,492,608 · 114 investors EDGAR ↗
| Filing | Form D filed Nov 13, 2019SEC file no. 021-353280 · accession 0000935836-19-000587 · filing 1 of 2 in this offering |
|---|
| Raise progress | $24,492,608 sold of $24,492,608 offered (100%) · $0 remaining · first sale Oct 29, 2019 |
|---|
| Filing timing | Date of first sale: Oct 29, 2019 · Form D filed: Nov 13, 2019 (15 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 2,552 days (7.0 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: Nov 14, 2019 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 114 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $1 |
|---|
| Securities offered | Equity; Option, warrant or other right to acquire; Other: Common Stock and Warrants to Purchase Common Stock · business combination transaction |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Jacob Margolin, Chief Executive Officer (Nov 13, 2019) |
|---|
| Market context | Minimum investment: $1. Typical range for similar offerings: $10,000–$54,310.
Offering size: $24,492,608. Typical range: $829,831–$9,999,998.
Investors: 114. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Amendment history — 2 amendments on this page, each compared with the filing before it in the same offering
| Amendment filed | File no. | Compared with | What changed (both values as filed) |
|---|
| Dec 15, 2021 EDGAR ↗ | 021-401053 | May 28, 2021 D | total sold: $1,925,000 (May 28, 2021) → $11,321,875 (Dec 15, 2021) · total offering: $2,000,000 (May 28, 2021) → Indefinite (Dec 15, 2021) · remaining: $75,000 (May 28, 2021) → Indefinite (Dec 15, 2021) · and 2 more (open the filing above) |
| Nov 14, 2019 EDGAR ↗ | 021-353280 | Nov 13, 2019 D | No change in the fields compared |
Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Values as filed; no conclusion is drawn.
All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Oct 17, 2023. Industry as reported, by offering: Previous offerings: Other Health Care (2019–2022). Latest offering: Hospitals and Physicians (Oct 17, 2023).
Key people 28
Officers, directors and promoters the issuer itself named on its Form D. Tap a name for every other deal they are on.
| Name | Relationship | Address state | On filings (first → last) | Also listed on |
|---|
| CG Cheryl Grenas | Director | TX | Apr 12, 2022 → Oct 17, 2023 on 2 of 8 filings listed on the latest filing | — |
| DS Danniel Stites | Director | TX | Oct 17, 2023 on 1 of 8 filings listed on the latest filing | — |
| EL Elisa Luqman | Executive Officer, Director Issuer's note: Executive Vice President of Finance, General Counsel | TX | Nov 13, 2019 → Oct 17, 2023 on 8 of 8 filings listed on the latest filing | 2 other issuers |
| JW John Waters | Director | TX | Nov 13, 2019 → Oct 17, 2023 on 8 of 8 filings listed on the latest filing | — |
| JB Jon Bates | Executive Officer | TX | Oct 17, 2023 on 1 of 8 filings listed on the latest filing | — |
| MR Michael Reed | Director | TX | Apr 12, 2022 → Oct 17, 2023 on 2 of 8 filings listed on the latest filing | — |
| MC Mitchell Creem | Director | GA, FL, TX | Nov 13, 2019 → Oct 17, 2023 on 8 of 8 filings listed on the latest filing | — |
| PM Pamela Montgomery | Executive Officer | TX | Apr 12, 2022 → Oct 17, 2023 on 2 of 8 filings listed on the latest filing | — |
| TV Thomas Vo | Executive Officer, Director | TX | Apr 12, 2022 → Oct 17, 2023 on 2 of 8 filings listed on the latest filing | — |
| WH Warren Hosseinionn | Executive Officer, Director | TX | Oct 17, 2023 on 1 of 8 filings listed on the latest filing | 2 other issuers |
| DP Denise Pufal | Executive Officer | TX | Apr 12, 2022 on 1 of 8 filings not listed on the latest filing (Oct 17, 2023) | — |
| LS Lawrence Schimmel | Executive Officer, Director Issuer's note: Chief Medical Information Officer | TX | Nov 13, 2019 → Apr 12, 2022 on 5 of 8 filings not listed on the latest filing (Oct 17, 2023) | 3 other issuers |
| MY Matthew Young | Director | TX | Apr 12, 2022 on 1 of 8 filings not listed on the latest filing (Oct 17, 2023) | — |
| MB Michael Bowen | Executive Officer Issuer's note: Chief Financial Officer | TX | Mar 12, 2021 → Apr 12, 2022 on 3 of 8 filings not listed on the latest filing (Oct 17, 2023) | 5 other issuers |
| MC Michael Chang | Executive Officer | TX | Apr 12, 2022 on 1 of 8 filings not listed on the latest filing (Oct 17, 2023) | 1 other issuer |
| WH Warren Hosseinion | Director, Executive Officer Issuer's note: Chief Executive Officer, Chairman of the Board | TX | Nov 13, 2019 → Apr 12, 2022 on 5 of 8 filings not listed on the latest filing (Oct 17, 2023) | 5 other issuers |
| BS Brandon Sims | Director | FL | Dec 15, 2021 on 1 of 8 filings not listed on the latest filing (Oct 17, 2023) | — |
| DM David Meiri | Director | GA | Nov 13, 2019 → Dec 15, 2021 on 6 of 8 filings not listed on the latest filing (Oct 17, 2023) | 1 other issuer |
| FS Fred Sternberg | Executive Officer, Director Issuer's note: President | FL | Mar 12, 2021 → Dec 15, 2021 on 3 of 8 filings not listed on the latest filing (Oct 17, 2023) | 1 other issuer |
| HW Hosseinion Warren | Executive Officer, Director | FL | May 28, 2021 → Dec 15, 2021 on 2 of 8 filings not listed on the latest filing (Oct 17, 2023) | — |
| JM Jacob Margolin | Executive Officer, Director | GA | Nov 13, 2019 → Dec 15, 2021 on 6 of 8 filings not listed on the latest filing (Oct 17, 2023) | 1 other issuer |
| MF Mark Fawcett | Director | GA | Nov 13, 2019 → Dec 15, 2021 on 4 of 8 filings not listed on the latest filing (Oct 17, 2023) | 1 other issuer |
| RC Robert Chan | Director | FL | May 28, 2021 → Dec 15, 2021 on 2 of 8 filings not listed on the latest filing (Oct 17, 2023) | — |
| TB Terrence Breslin also filed as Terrence Martin Breslin | Director | FL | Mar 12, 2021 → Dec 15, 2021 on 3 of 8 filings not listed on the latest filing (Oct 17, 2023) | — |
| AB Andrew Barnett | Executive Officer Issuer's note: Executive Vice President of Corporate Development | FL | Mar 12, 2021 on 1 of 8 filings not listed on the latest filing (Oct 17, 2023) | — |
| RS Randall Stern | Director | FL | Mar 12, 2021 on 1 of 8 filings not listed on the latest filing (Oct 17, 2023) | — |
| RC Richard Chan | Director | FL | Mar 12, 2021 on 1 of 8 filings not listed on the latest filing (Oct 17, 2023) | — |
| TB Terence Martin Breslin | Director | GA | Nov 13, 2019 → Jan 22, 2020 on 3 of 8 filings not listed on the latest filing (Oct 17, 2023) | — |
Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings of the same name (same first and last name, or the same full name that EDGAR split differently into middle and last name) with no conflicting middle initial are shown on one row (each spelling that has its own person page is linked); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗. Middle names: the SEC Form D data set (RELATEDPERSONS.tsv) repeats the previous person's middle name into later rows of the same filing; where that happened PartnerFacts shows the name without the repeated middle name and keeps the data-set spelling on record (Elisa Martin Luqman; John Martin Waters; Mitchell Martin Creem; David Martin Meiri; Jacob Martin Margolin; Mark Martin Fawcett; Randall Martin Stern) — the filing on EDGAR is the source.
Connections
Other issuers listing the same people:
- goBU, Inc. — Michael Bowen · latest filing Apr 21, 2026
- SWNB BANCORP INC — Michael Chang · latest filing Feb 4, 2026
- Astrana Health, Inc. — Warren Hosseinion · latest filing Nov 21, 2025
- Astrana Health, Inc. — Mark Fawcett · latest filing Nov 21, 2025
- Vesicor Therapeutics, Inc. — Warren Hosseinion · latest filing May 14, 2025
- Vesicor Therapeutics, Inc. — Michael Bowen · latest filing May 14, 2025
- Vesicor Therapeutics, Inc. — Warren Hosseinionn · latest filing May 14, 2025
- Altitude Capital Holdings LLC — Warren Hosseinion · latest filing Oct 2, 2024
- Cardio Diagnostics Holdings, Inc. — Elisa Luqman · latest filing Feb 6, 2024
- Cardio Diagnostics Holdings, Inc. — Warren Hosseinionn · latest filing Feb 6, 2024
- Speakeasy Commerce Inc. — Michael Bowen · latest filing Mar 13, 2023
- Cardio Diagnostics Inc. — Warren Hosseinion · latest filing Oct 5, 2022
- Cardio Diagnostics Inc. — Elisa Luqman · latest filing Oct 5, 2022
- Accountable Healthcare America Inc. — Michael Bowen · latest filing Jul 21, 2020
- Accountable Healthcare America Inc. — Fred Sternberg · latest filing Jul 21, 2020
- Clinigence Holdings, Inc. — Warren Hosseinion · latest filing May 6, 2019
- Clinigence Holdings, Inc. — Jacob Margolin · latest filing May 6, 2019
- Clinigence Holdings, Inc. — Lawrence Schimmel · latest filing May 6, 2019
- Clinigence Holdings, Inc. — David Meiri · latest filing May 6, 2019
- Professional Holding Corp. — Lawrence Schimmel · latest filing Dec 19, 2018
- QUALMETRIX, INC. — Lawrence Schimmel · latest filing Jun 3, 2015
- Breitling Oil & Gas Corp — Michael Bowen · latest filing Jan 9, 2013
Shared address: this business address appears on no other issuer's filings in our index. As of Oct 23, 2026, 5:45 PM ET.
Other offering types (Regulation A and Regulation Crowdfunding)
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Adviser registration (Form ADV)
Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched Nutex Health, Inc..
Meta advertising
No Meta Pixel ids or Facebook / Instagram page links on file for Nutex Health, Inc. as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.
Public profiles
Public profiles official links and public statements, each with its source and date
No website or social profile named in Nutex Health, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #1,460 of 374,652 in line (14 issuers searched so far).
Sources searched for a website: Form C data set (issuer websites as filed), Form ADV data set (Item 1.I of matched advisers) — as of Oct 23, 2026, 11:20 PM ET: none on file for this issuer. The sponsor website, the Internet Archive and GDELT news index are read only once a site is on file; a sponsor's website comes from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim, Form ADV Item 1.I of its matched adviser, or a web search for the issuer name confirmed on the site's own homepage. We never collect personal or family accounts.
Entity standing: not checked (no official programmatic source for TX yet).
Export this report as PDF (all source links + data timestamp) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
Corrections log
No corrections have been requested for this page.
Filing-to-filing changes are in Amendment history above.